Coverage Rights

com.coverage-rights由 coverage-rights.com 發布官方發布者v1.1.0更新於 Oct 24, 2026

Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.

已驗證Streamable HTTP可網頁執行金融

概覽

AI 產生的概覽

讓助理查詢保險公司的拒賠率、依治療方式與病症區分的申訴結果，以及申訴權利資訊。

可以做什麼
這是一個遠端 MCP 伺服器，提供與健康保險理賠相關的查詢：保險公司拒賠率、依治療方式與病症細分的申訴結果，以及申訴權利資訊。清單中沒有列出任何工具，因此具體工具名稱與參數在此無法說明。它透過可串流 HTTP 連線至託管端點存取，而非在使用者本機執行。
適用情境
當助理需要回答某家保險公司拒賠頻率、特定治療或病症的申訴通常結果如何，或適用哪些申訴權利時，適合加入。對於拒賠與申訴資料之外的普通醫療、帳務或保險報價問題，幫助不大。
執行需求
需要一個遠端可串流 HTTP 端點；未宣告本機執行環境、套件、環境變數或標頭。清單未宣告任何身分驗證，因此沒有記錄帳號或 API 金鑰。需要能連線至該供應商的端點。
安裝前請注意
清單未宣告身分驗證，因此請求帶有何種身分、供應商記錄哪些資料都不明確。關於治療與病症的查詢可能向第三方服務揭露敏感健康資訊，應避免送出可識別病患身分的資料。依賴拒賠率與申訴數據前，請確認其準確性與時效性。

安裝

在 SourceWeft 中

  1. 開啟 儀表板中的 Coverage Rights，將其新增到工作區。
  2. 為需要使用其工具的對話啟用該服務。

Web executable，透過 Streamable HTTP。 遠端服務在工作區中設定後即可從網頁執行環境執行。

交給代理程式安裝

把這段提示詞貼上到 Claude Code、Codex、Cursor 等代理程式，或 SourceWeft 對話中。代理程式會讀取該伺服器的安裝指南，先向你展示發布者、端點和登入方式，經你同意後再把它新增到你的客戶端。金鑰不會寫進任何命令。

閱讀 https://sourceweft.com/mcp/com.coverage-rights%2Fcoverage-rights/install.md，並按其中說明把這個 MCP 伺服器接入我的客戶端。修改任何設定之前，先告訴我它的發布者、端點和登入方式，等我確認。不要把 API 金鑰寫進命令或我會提交的檔案；問我金鑰應從哪裡取得。

檢視代理程式所依據的安裝指南

其他 MCP 客戶端

把它新增到你客戶端的 mcpServers 設定中。

{
  "mcpServers": {
    "coverage-rights": {
      "type": "http",
      "url": "https://www.coverage-rights.com/api/mcp"
    }
  }
}

工具

9

list_insurers

List insurers

List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.

無需輸入參數。

get_insurer_metrics

Insurer denial metrics

Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.

輸入參數slug必填

rank_denial_rates

Denial rates ranked

Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.

無需輸入參數。

get_treatment_outcomes

Treatment denial outcomes

External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').

輸入參數slug必填

get_condition_outcomes

Condition denial outcomes

External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.

輸入參數slug必填

search_outcomes

Search outcomes

Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.

輸入參數limitquery必填

get_appeal_rights

Appeal rights lookup

Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, TRICARE, and unknown coverage; unsupported or ambiguous routes fail closed.

輸入參數stateprogram必填appeal_stagedrug_channelinsurer_slugdenial_reason必填employer_typecurrent_statusfunding_statusregulatory_markerregulatory_state_basis

get_drug_playbook

Drug denial playbook

Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that specific drug, what winning appeals argue, and the step-therapy exception framing — plus the published external-review record for the drug when the corpus has it. Accepts a brand or generic name.

輸入參數drug必填

get_state_external_review

State external review

How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.

輸入參數state必填

版本歷史

1
  1. v1.1.0最新Sep 16, 2026

評分

已滿足適用檢查項的 83%

該評分衡量此收錄條目的完整程度，依據註冊中心條目、端點與公開來源計算得出。它不是對伺服器本身的評價，也不表示伺服器安全或目前可用：可連通性是帶日期的檢查結果，評分也不包含安裝量或使用者評價。

  • 近 30 天內可連通必需25 分
  • 已宣告認證方式必需10 分
  • 已列出工具必需15 分
  • 描述必需15 分
  • 圖示10 分
  • 文件15 分

    請宣告包含 README 的 GitHub 儲存庫，或在 OAuth 受保護資源後設資料中提供 resource_documentation。

  • 授權條款不適用

    託管服務按其提供方的條款使用，因此這裡不要求授權條款。此檢查項不計入百分比。